Letko, Brosseau & Associates’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
Letko, Brosseau & Associates's ADNT Position: Q3 2026 in Review
Letko, Brosseau & Associates increased its Adient (ADNT) stake by 0.09% in Q3 2026, buying an estimated $29.4K and bringing the position to 1,662,596 shares worth $28M. The position accounts for 0.41% of the portfolio, ranked #63.
Letko, Brosseau & Associates first reported a position in ADNT in Q4 2016 and has held it in 28 quarters since. The position peaked at $81M in Q1 2021. 304 funds tracked by Wall St. Rank hold ADNT as of Q3 2026.
- Letko, Brosseau & Associates held 1,662,596 shares of Adient worth $28M as of Q3 2026.
- Letko, Brosseau & Associates bought 1,524 Adient shares in Q3 2026, an estimated $29.4K.
- Adient made up 0.41% of Letko, Brosseau & Associates's portfolio in Q3 2026, its #63 holding.
- Letko, Brosseau & Associates first reported a position in Adient in Q4 2016 and has held it in 28 quarters since.
- Letko, Brosseau & Associates's Adient position peaked at $81M in Q1 2021.
- 304 funds tracked by Wall St. Rank held Adient as of Q3 2026.
Based on Letko, Brosseau & Associates's 13F filing for Q3 2026, filed 6 Nov 2026.